Trial Profile
Corifollitropin Alfa in Combination With Elective Cryopreservation of All Embryos After GnRH Agonist Triggering of Final Oocyte Maturation in PCOS Patients- a Prospective, Observational Proof-of -Concept Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary)
- Indications Female infertility
- Focus Adverse reactions; Proof of concept
- 02 Nov 2018 Status changed from recruiting to completed.
- 19 Aug 2014 New trial record